Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Dermapharm Holding SE buy DaxiDriver

Start price
€61.85
17.02.21 / 80%
Target price
€90.00
17.02.22
Performance (%)
41.23%
End price
€87.35
25.12.21
Summary
This prediction ended on 25.12.21 with a price of €87.35. The BUY prediction by DaxiDriver for Dermapharm Holding SE saw massive gains of 41.23%. DaxiDriver has 80% into this prediction

Dermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.

Performance without dividends (%)
Name 1w 1m 1y 3y
Dermapharm Holding SE -4.054% -4.054% -24.073% -58.181%
iShares Core DAX® -1.785% -1.250% 11.664% 12.714%
iShares Nasdaq 100 -2.154% 0.300% 37.531% 41.653%
iShares Nikkei 225® -4.028% -3.746% 17.142% 0.393%
iShares S&P 500 -1.969% 0.307% 25.617% 40.084%

Comments by DaxiDriver for this prediction

In the thread Dermapharm Holding SE diskutieren
Prediction Buy
Perf. (%) 41.23%
Target price 90.000
Change
Ends at 17.02.22

Buy mit Kursziel 90,0